William Tai-Wei Ho - 14 Apr 2023 Form 4/A - Amendment Insider Report for IN8BIO, INC. (INAB)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
INAB
Transactions as of
14 Apr 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
23 Jun 2023, 18:25:13 UTC
Date Of Original Report
18 Apr 2023
Previous filing
25 Oct 2022
Next filing
23 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INAB Employee Stock Option (right to buy) Award $0 +393,950 $0.000000 393,950 14 Apr 2023 Common Stock 393,950 $1.21 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The initial Form 4 inadvertently listed the wrong exercise price and expiration date. This amendment reflects the revised exercise price and expiration date for this option.
F2 Twenty-five percent (25%) of the shares subject to the option shall vest on April 14, 2024 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.